Trends and Disparities in Cardiovascular Mortality Among Survivors of Hodgkin Lymphoma

Clinical Lymphoma, Myeloma & Leukemia
Sadeer G Al-KindiGuilherme H Oliveira

Abstract

Over the past decades, survival of patients with Hodgkin lymphoma (HL) has increased but remains curtailed by cardiovascular mortality (CVM). HL survivors at greatest risk for cardiovascular death have not been clearly identified. We sought to report trends of CVM identify HL survivors at highest risk. The Surveillance, Epidemiology, and End Results (SEER) database was queried for all adult patients diagnosed with HL (age 20-49 years) between 1990 and 2011. The trend of CVM and disparities are presented. Of 19,781 HL patients, 53% were male and 83% were white; patients had a mean age of 33 ± 8.3 years at diagnosis. Eighteen percent had stage I disease, 45% stage II, 18% stage III, and 15% stage IV. The risk for CVM was higher in blacks (adjusted hazard ratio [HR], 1.97; P = .002), men (adjusted HR, 2.2; P < .001), and patients with older age at diagnosis (adjusted HR, 1.073 per year; P < .001). CVM has decreased, with 5-year cumulative incidence decreasing from 1.17% in 1990 to 0.18% in 2006, averaging 7% per year (adjusted HR, 0.927; P < .001). This trend was seen only in patients with early disease (P < .001) but not with advanced disease (P = NS). CVM as a proportion of all-cause mortality increases sharply at 50 years of ag...Continue Reading

References

Dec 1, 1970·Annals of Internal Medicine·V T DevitaP P Carbone
Dec 1, 2001·International Journal of Radiation Oncology, Biology, Physics·U RühlW Dörffel
Mar 7, 2002·Journal of Pediatric Hematology/oncology·K C OeffingerB M Foster
Apr 17, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrea K NgPeter M Mauch
Jul 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Berthe M P AlemanFlora E van Leeuwen
Aug 23, 2003·Journal of the American College of Cardiology·Paul A HeidenreichIngela Schnittger
Dec 6, 2003·JAMA : the Journal of the American Medical Association·Matthew C HullNancy Price Mendenhall
Jan 1, 2004·The Lancet Oncology·Volker DiehlDaniel Re
Aug 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mary C PinderSharon H Giordano
Jan 9, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Lillian R MeachamAnn C Mertens
Apr 2, 2013·Seminars in Oncology·Maria Martinou, Andrew Gaya
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Jan 21, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·George P CanellosVincent T Devita
May 20, 2014·The American Journal of Cardiology·Guilherme H OliveiraW H Wilson Tang

❮ Previous
Next ❯

Citations

Mar 10, 2016·Journal of Adolescent and Young Adult Oncology·Arya AminiArthur K Liu
Mar 22, 2016·Cancer Medicine·Matthew KoshyUsama Mahmood
Nov 18, 2016·Journal of Cancer Survivorship : Research and Practice·Melanie R KeatsLouise Parker
Dec 2, 2017·Expert Review of Anticancer Therapy·Mohamed Gomaa KamelNguyen Tien Huy
Dec 20, 2017·Journal of Cancer Research and Clinical Oncology·Aasems JacobDavid Sharon
Sep 19, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Graça M DoresLindsay M Morton
Apr 2, 2021·American Society of Clinical Oncology Educational Book·Demetria Smith-Graziani, Christopher R Flowers
Jan 26, 2021·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Lili ZhangAhmed A Tawakol

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Rebecca L SiegelElizabeth M Ward
International Forum of Allergy & Rhinology
Tapan D PatelJean Anderson Eloy
© 2021 Meta ULC. All rights reserved